RAB23 and gastric cancer: As shown in Fig. 3, analysis of relative expression levels indicated that IHH, BOC, and RAB23 were decreased in 48%, 54%, and 42% of gastric cancer tissues while 32%, 30%, and 34% of cases showed IHH, BOC, and RAB23 overexpression, respectively.